Howard Marks's position in Core Scientific is currently worth $207M. That's 4.90% of their equity portfolio (5th largest holding). The investor owns 2.70% of the outstanding Core Scientific stock. The stake costed the investor $146M, netting the investor a gain of 42% so far.